Medical News

RSS

FDA warns against consumption of Tiny Greens brand Alfalfa Sprouts or Spicy Sprouts

The FDA is advising consumers not to eat Alfalfa Sprouts and Spicy Sprouts (which contain alfalfa sprouts mixed with radish and clover sprouts) from Tiny Greens Organic Farm of Urbana, Ill. The sprouts were distributed in 4 oz. and 5 lb. containers to various customers, including farmers' markets, restaurants and groceries, in Illinois, Indiana, Iowa, Missouri and possibly other Midwestern states.

28 Dec 2010

Myrexis initiates controlled two-arm Azixa Phase 2b clinical study in glioblastoma multiforme

EpiCept Corporation today reported that Myrexis, Inc. has initiated a controlled two-arm Phase 2b clinical study of Azixa™ as a front-line treatment for glioblastoma multiforme (GBM). Azixa™, a vascular disruption agent with potent anti-cancer activity, was discovered by EpiCept as part of its ASAP technology platform and licensed to Myrexis.

28 Dec 2010

NIIT Technologies forays into US health care segment with acquisition of Preferr EHR

NIIT Technologies Limited, a leading IT solutions organization has acquired an electronic health records and referral management platform to initiate its foray into the lucrative health care segment in the US. The platform called "Preferr" (Patient Referral System)" enables seamless collaboration between all providers namely physicians, hospitals, diagnostic facilities, and laboratories.

28 Dec 2010

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Advanced Cell Technology, a leader in the field of regenerative medicine, announced today that it has entered into a Memorandum of Understanding with Roslin Cells LTD of Scotland, in which the two companies contemplate a definitive collaboration agreement in the near future.

28 Dec 2010

Turns mortal heart attacks into non-mortal heart attacks -- NIH study

Three weeks of oral resveratrol or Longevinex- ingestion prior to an induced heart attack returned microRNA activity close to their pre-event levels in excised animal hearts. Among thousands of microRNA's studied, just six were attributed to exerting the majority of the gene-switching effects measured in the animal heart study - four microRNA optimally regulated by Longevinex- and two optimally by plain resveratrol.

28 Dec 2010

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Dana Farber/Harvard Cancer Center will launch a new multi-million dollar grant award program focused on prostate cancer research. It will be administered in collaboration with the Prostate Cancer Foundation.

28 Dec 2010

Cephalon receives second FDA Complete Response Letter for NUVIGIL sNDA

Cephalon, Inc. today announced that the company received a second Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the supplemental new drug application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV] for the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel. In its letter to the company, the FDA reiterated its previously stated concerns regarding the NUVIGIL sNDA.

28 Dec 2010

King Pharmaceuticals resubmits NDA for REMOXY

King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.

28 Dec 2010

Discovery Labs to implement reverse stock split

Discovery Laboratories, Inc. today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Amendment") to effect a 1-for-15 share consolidation, or reverse stock split ("reverse split"), effective at 12:01 a.m. on December 28, 2010 (the "Effective Time").

28 Dec 2010

Biglycan protein offers potential therapy for muscular dystrophy

A novel potential therapy based on a natural human protein significantly slows muscle damage and improves function in mice who have the same genetic mutation as boys with the most common form of muscular dystrophy, according to a paper published online Dec. 27 in the Proceedings of the National Academy of Sciences.

28 Dec 2010

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

Vicus Therapeutics, LLC, today announced the initiation of a Phase 2 trial evaluating VT-122, a novel investigational combination of etodolac and propranolol, and Nexavar® (sorafenib) tablets, as a potential new treatment option for patients with advanced liver cancer (hepatocellular carcinoma), systemic inflammation and cachexia.

28 Dec 2010

NDA resubmitted for DURECT's ORADUR technology based REMOXY

DURECT Corporation today reported that King Pharmaceuticals, Inc. and Pain Therapeutics, Inc. have announced that King has resubmitted a New Drug Application (NDA) for REMOXY® to the U.S. Food and Drug Administration (FDA) in response to a Complete Response Letter received by Pain Therapeutics in December 2008. This is a Class 2 resubmission with a six month review cycle.

28 Dec 2010

Study sheds light on how bacteria developed resistance to antibiotics

Studying how bacteria incorporate foreign DNA from invading viruses into their own regulatory processes, Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, is uncovering the secrets of one of nature's most primitive immune systems.

27 Dec 2010

Palladium Equity Partners acquires Jordan Healthcare Holdings

Palladium Equity Partners, LLC, a private investment firm based in New York focused on investments in the U.S. Hispanic marketplace, announced today that one of its affiliates has acquired Jordan Healthcare Holdings, Inc. Terms were not disclosed.

27 Dec 2010

Emergent initiates AV7909 Phase I trail for Anthrax vaccine

Emergent BioSolutions today announced the initiation of a Phase I clinical trial for NuThraxTM, also known as AV7909, with the dosing of the first subject.

27 Dec 2010

Researchers receive $6.78 million NIH grant for community-based study on heart disease

Researchers at the Methodist DeBakey Heart & Vascular Center in Houston were recently awarded a $6.78 million grant from the National Institutes of Health to extend a 23-year-old large-scale, community-based study of heart disease.

27 Dec 2010

First “saviour sibling” procedure successful

In a first, a nine year old girl received tissue donated by her 18-month old brother Max who was created specifically so that he could aid her medical treatment – a procedure termed as “savior sibling”. This is the first time that the procedure has been under the supervision of British researchers from IVF onwards.

27 Dec 2010

Flu infection rates double in a week

Figures reveal that the rates of flu infection in the UK have more than doubled in the last week. Number of cases has risen to 87.1 per 100,000 people, from 32.8 in the previous week, according to the Royal College of GPs. Reports also reveal that school-age children from England and Wales are particularly affected. Ages five to 14 are highest affected followed by those under four, then people aged 15 to 44. Considering all age groups rates almost tripled in the South in one week, from 36 per 100,000 to 93.4. In the North, the rate was 55.5, up from 15.7, and was 94.9 in the central England region, up from 37.9.

27 Dec 2010

Cancer survival rates improving

Survival rates for cancers of the bowel, breast, lung and ovary that were diagnosed between 1995 and 2007 were compared between Australia, Canada, Denmark, Norway, Sweden and the UK. Overall, survival rates improved in all six countries. However, survival was found to be “persistently lower” in Denmark, England, Northern Ireland and Wales. This was particularly the case after the first year of diagnosis and for patients aged 65 and over. In UK cancer survival rates have improved significantly. Breast cancer survival at five years, for example, increased from 74.8% in 1995-9, to 81.6% in 2005-7. Despite this, the UK still has the lowest breast cancer survival rate at five years.

27 Dec 2010

Stress may boost memory: Study

In a new study researchers have found that stress can enhance ordinary, unrelated memories. This may open up new avenues in management of patients of post-traumatic stress disorder (PTSD) and related afflictions say experts.

27 Dec 2010

Medical News

FDA warns against consumption of Tiny Greens brand Alfalfa Sprouts or Spicy Sprouts

Myrexis initiates controlled two-arm Azixa Phase 2b clinical study in glioblastoma multiforme

NIIT Technologies forays into US health care segment with acquisition of Preferr EHR

ACT, Roslin Cells collaborate to establish hESC line bank using single-ceblastomere technique

Turns mortal heart attacks into non-mortal heart attacks -- NIH study

U.S judge awards $11.7 million to DF/HCC for large-scale prostrate cancer research

Cephalon receives second FDA Complete Response Letter for NUVIGIL sNDA

King Pharmaceuticals resubmits NDA for REMOXY

Discovery Labs to implement reverse stock split

Biglycan protein offers potential therapy for muscular dystrophy

Vicus initiates VT-122 Phase 2 trial in advanced liver cancer, systemic inflammation and cachexia

NDA resubmitted for DURECT's ORADUR technology based REMOXY

Study sheds light on how bacteria developed resistance to antibiotics

Palladium Equity Partners acquires Jordan Healthcare Holdings

Emergent initiates AV7909 Phase I trail for Anthrax vaccine

Researchers receive $6.78 million NIH grant for community-based study on heart disease

First “saviour sibling” procedure successful

Flu infection rates double in a week

Cancer survival rates improving

Stress may boost memory: Study

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News